About Netrin-5
Netrin-5 (NTN5) is a protein
from Homo sapiens identified by UniProt accession
Q8WTR8, 489 residues long.
MolForge cross-references it against 0 known binders and
115 disease associations.
Target properties
| Protein name | Netrin-5 |
| UniProt accession | Q8WTR8 |
| Gene | NTN5 |
| Organism | Homo sapiens |
| Length | 489 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (115)
Diseases linked to this target (Open Targets).
- alkaline phosphatase measurement · score 0.27
- Diarrhea · score 0.20
- body height · score 0.09
- anti-polyomavirus 2 antibody measurement · score 0.07
- age at menarche · score 0.07
- alcohol use disorder measurement · score 0.06
- triglyceride measurement · score 0.06
- mean corpuscular hemoglobin concentration · score 0.05
- hemoglobin measurement · score 0.05
- neutrophil count · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8WTR8-F1 | alphafold | PREDICTED | 83.59 | — |
Amino-acid sequence (489 residues)
MPVTFALLLL LGQATADPCY DPQGRPQFCL PPVTQLAAVA ASCPQACALS PGNHLGARET CNGSLTLALG GPFLLTSVSL RFCTPGPPAL ILSAAWASGG PWRLLWHRPA WPGALGGPER VTFHSTPGPK ATVAASHLRV EFGGQAGLAA AGLRGRCQCH GHAARCAARA RPPRCHCRHH TTGPGCESCR PSHRDWPWRP ATPRHPHPCL PCSCNQHARR CRFNSELFRL SGGRSGGVCE RCRHHTAGRH CHYCQPGFWR DPSQPIFSRR ACRACQCHPI GATGGTCNQT SGQCTCKLGV TGLTCNRCGP GYQQSRSPRM PCQRIPEATT TLATTPGAYS SDPQCQNYCN MSDTRVHMSL RRYCQQDHVL RAQVLASEAA GPAWQRLAVR VLAVYKQRAQ PVRRGDQDAW VPRADLTCGC LRLQPGTDYL LLGSAVGDPD PTRLILDRHG LALPWRPRWA RPLKRLQQEE RAGGCRGVRA PTPSPRPEH
Explore Netrin-5 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets